Login / Signup

Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model.

Woo-Jin JeonHong-Ki LeeYoung-Guk NaMinwoo JungSu-Cheol HanJeong Ho HwangEunhye JungDasom HwangJin Soo ShinCheong-Weon Cho
Published in: International journal of nanomedicine (2023)
Thus, the application of NLC against SARS-CoV-2 may be a beneficial strategy to improve the antiviral effects of antiviral agents.
Keyphrases
  • sars cov
  • drug delivery
  • respiratory syndrome coronavirus
  • cancer therapy
  • fatty acid
  • coronavirus disease
  • wound healing